2025-05-02 10:16:17
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Indoco Remedies Q4FY22 consolidated PAT higher at Rs. 40.45 crores
Posted On : 2022-05-17 13:03:09( TIMEZONE : IST )
Indoco Remedies Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 409.43 crores during the period ended March 31, 2022 as compared to Rs. 358.16 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 40.45 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 32.99 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 4.39 for the period ended March 31, 2022 as compared to Rs. 3.58 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 409.43 crs | ₹358.16 crs |  14.31% |
| Net Profit | ₹40.45 crs | ₹32.99 crs | 22.61% |
| EPS | ₹4.39 | ₹3.58 | 22.63% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 409.43 crores during the period ended March 31, 2022 as compared to Rs.307.12 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.40.45 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.25 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.4.39 for the period ended March 31, 2022 as compared to Rs.2.71 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 409.43 crs | ₹307.12 crs | 33.31% |
| Net Profit | ₹40.45 crs | ₹25 crs | 61.80% |
| EPS | ₹4.39 | ₹2.71 | 61.99% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1543.08 crores during the Financial Year ended March 31, 2022 as compared to Rs.1244.65 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.154.80 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.93.05 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.16.80 for the Financial Year ended March 31, 2022 as compared to Rs.10.10 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹1543.08 crs | ₹1244.65 crs | 23.98% |
| Net Profit | ₹154.80 crs | ₹93.05 crs | 66.36% |
| EPS | ₹16.80 | ₹10.10 | 66.34% |
Shares of Indoco Remedies Limited was last trading in BSE at Rs. 331.60 as compared to the previous close of Rs. 336.35. The total number of shares traded during the day was 1823 in over 534 trades.
The stock hit an intraday high of Rs. 338.50 and intraday low of 327.00. The net turnover during the day was Rs. 604794.00.
